Follow the 바이오톡스텍 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오톡스텍 has recorded 38 reports. Market capitalisation: €32.3bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 강종구. The full history is free.
38
Insider Decl.
n/a
Thresholds
n/a
28 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,187 of 29,063 companies
44.2
score / 100
Value
67
Quality
21
FCF yld14%
Earn yld3.6%
EV/EBITDA10.1x
ROE·
Gross mgn13%
Net mgn2.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioToxTech es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones innovadoras para el diagnóstico y tratamiento de enfermedades.